These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease. Mehta N; Gava AL; Zhang D; Gao B; Krepinsky JC Antioxid Redox Signal; 2019 Sep; 31(8):551-571. PubMed ID: 31184201 [No Abstract] [Full Text] [Related]
8. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Ziyadeh FN; Wolf G Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694 [TBL] [Abstract][Full Text] [Related]
9. The balance of powers: Redox regulation of fibrogenic pathways in kidney injury. Okamura DM; Pennathur S Redox Biol; 2015 Dec; 6():495-504. PubMed ID: 26448394 [TBL] [Abstract][Full Text] [Related]
11. Advanced oxidation protein products induce endothelial-to-mesenchymal transition in human renal glomerular endothelial cells through induction of endoplasmic reticulum stress. Liang X; Duan N; Wang Y; Shu S; Xiang X; Guo T; Yang L; Zhang S; Tang X; Zhang J J Diabetes Complications; 2016; 30(4):573-9. PubMed ID: 26861949 [TBL] [Abstract][Full Text] [Related]
12. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease. Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852 [TBL] [Abstract][Full Text] [Related]
13. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis. Picken M; Long J; Williamson GA; Polichnowski AJ Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923 [TBL] [Abstract][Full Text] [Related]
14. AOPPs and the progression of kidney disease. Cao W; Hou FF; Nie J Kidney Int Suppl (2011); 2014 Nov; 4(1):102-106. PubMed ID: 26312159 [TBL] [Abstract][Full Text] [Related]
15. Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation. Colombo G; Reggiani F; Angelini C; Finazzi S; Astori E; Garavaglia ML; Landoni L; Portinaro NM; Giustarini D; Rossi R; Santucci A; Milzani A; Badalamenti S; Dalle-Donne I Oxid Med Cell Longev; 2020; 2020():2975256. PubMed ID: 33299524 [TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of kidney fibrosis. Djudjaj S; Boor P Mol Aspects Med; 2019 Feb; 65():16-36. PubMed ID: 29909119 [TBL] [Abstract][Full Text] [Related]
17. Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats. Jing W; Nunes ACF; Farzaneh T; Khazaeli M; Lau WL; Vaziri ND J Pharmacol Exp Ther; 2018 Oct; 367(1):129-137. PubMed ID: 30093458 [TBL] [Abstract][Full Text] [Related]
18. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516 [TBL] [Abstract][Full Text] [Related]
19. Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? Duni A; Liakopoulos V; Rapsomanikis KP; Dounousi E Oxid Med Cell Longev; 2017; 2017():9036450. PubMed ID: 29333213 [TBL] [Abstract][Full Text] [Related]